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Results LIST induced transient increases in leukocytes, 
granulocytes, CK, muscle soreness, CRP, IL-6 and declines 
in lymphocytes and performance indices. Supplementa-
tion resulted in a faster recovery of SQJ, CK and CRP 
compared to pre-supplementation kinetics (trial  ×  time: 
p = 0.001, 0.056, 0.014, respectively) and lower incremen-
tal area under the curve (iAUC) for IL-6, only in the BC 
group [pre-: 31.1 (6.78–46.9), post-: 14.0 (−0.16 to 23.5) 
pg  h/ml, p = 0.034]. Direct comparison of the two groups 
after supplementation demonstrated higher iAUC of SQJ 
[WP: −195.2 (−229.0 to (−52.5)), BC: −15.8 (−93.2 
to 16.8) cm  h, p = 0.034], a trend for lower iAUC of CK 
in the BC group [WP: 18,785 (4651–41,357), BC: 8842 
(4807–14,802) U h/L, p = 0.081] and a significant interven-
tion × time interaction for CRP (p = 0.038) in favor of BC.
Conclusions Post-exercise EIMD may be reduced and 
performance better maintained by a low dose of BC admin-
istration following LIST in soccer players.
Keywords Bovine colostrum · Exercise-induced muscle 
damage · Loughborough Intermittent Shuttle Test · Soccer · 
Inflammation · Squat jump
Abbreviations
iAUCs  Incremental area under the curve
BC  Bovine colostrum
CK  Creatine kinase
CMJ  Counter movement jump
CRP  C-reactive protein
EIMD  Exercise-induced muscle damage
IL-6  Interleukin-6
LIST  Loughborough Intermittent Shuttle Test
MIVC  Maximum isometric voluntary contraction
SQJ  Squat jump
Abstract 
Purpose The aim of the study was to investigate the effect 
of a 6-week, low-dose bovine colostrum (BC) supplemen-
tation on exercise-induced muscle damage (EIMD) and 
performance decline in soccer players following the Lough-
borough Intermittent Shuttle Test (LIST) during a competi-
tive season period.
Methods In a double-blind, randomized, placebo-con-
trolled design, two groups of soccer players were allocated 
to a 3.2 g/day of whey protein (WP, N = 8) or BC (N = 10) 
and performed a pre- and a post-supplementation LIST. 
Maximum isometric voluntary contraction, squat jump 
(SQJ), countermovement jump, muscle soreness, blood 
cell counts, creatine kinase (CK), C-reactive protein (CRP) 
and interleukin-6 (IL-6) were monitored for 2, 24, 48, 72 h 
post-LIST.
The study was investigator initiated and the sponsor had no 
involvement in the design and conduct of the study, in the 
collection, management analysis and interpretation of the data 
or in the preparation, review or approval of the manuscript. The 
corresponding author had full access to all the data in the study 
and had the final responsibility for the decision to submit for 
publication.
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VAS  Visual analog scale
WP  Whey protein
Introduction
Elite-level soccer games are characterized by high-intensity 
intermittent physical activity. The repetitive and eccen-
tric nature of soccer movements (accelerations, decelera-
tions, kicking, jumping, and tackling) can cause muscle 
damage, accompanied by the leakage of muscle enzymes 
and other functional proteins in the circulation, oxidative 
stress, inflammation and decline in muscle performance 
[1, 2]. The clinical phenotype of post-match muscle dam-
age can strongly impair the recovery process [3]. Taking 
into account the congested schedule of elite soccer players 
(2 or even 3 matches per week) the recovery period is not 
optimal for the restoration of pre-match exercise capacity 
and performance, while it may increase the risk for muscle 
injuries [4].
Since the extent of muscle damage can determine the 
duration of the recovery period, several strategies, aim-
ing to attenuate muscle damage and accelerate the recov-
ery period, are under research. However, the majority is 
adopting physiotherapeutic and training modalities like 
stretching, cryotherapy, active recovery, sleeping, mas-
sage, electrical stimulation and compression garments [5], 
while the nutritional or supplementation interventions are 
much less studied under real post-soccer match conditions. 
Interventions including the administration of creatine [6], 
antioxidant vitamins [7, 8], astaxanthin [9], beta-alanine 
[10], omega-3 fatty acids [11] are tested for their abil-
ity to reduce exercise-induced muscle damage (EIMD) or 
to increase exercise performance after a soccer match or a 
simulation of a soccer match. However, the results so far 
are inconclusive concerning the ability of supplements to 
improve the recovery process [5].
Bovine colostrum (BC) is the first milk produced by 
the mammary glands of the mother during the final days 
of pregnancy and the first days postpartum (1–4 days). It 
is as rich in carbohydrates, proteins, fats and micro-nutri-
ents (minerals, trace elements) as the regular milk, but it 
additionally contains high amounts of oligosaccharides, 
growth factors, antimicrobial agents and immunoregulatory 
compounds [12]. It is therefore a natural multi-ingredient 
supplement with potential pleiotropic properties. Previ-
ous studies focused, mainly, on its effect on exercise per-
formance, body composition [13], immune system and its 
ability to counteract upper respiratory tract infections [14]. 
However, the doses of BC in these studies were relatively 
high (20–60 g/day). So far, the ability of BC to enhance the 
recovery after a high-intensity soccer match is implied only 
indirectly through its anabolic properties [15], its buffering 
capacity [16] and its ability to attenuate post-exercise intes-
tinal permeability [17] and oxidative stress [18]. In order to 
shed more light on this issue, aim of the present study was 
to investigate the effect of a low-dose BC supplementation 
on EIMD and performance in soccer players, during their 
competitive season, following the Loughborough Intermit-
tent Shuttle Test (LIST) which simulates the activity pat-
tern of a real soccer match [19].
Materials and methods
Study design
The study had a double-blind, randomized, placebo-con-
trolled, parallel group, design. Participants initially com-
pleted a pre-supplementation LIST (LIST 1) and muscle 
damage indices were monitored for 72  h post-exercise. 
Then, they randomly allocated to the whey protein (WP) or 
BC group, received the respective supplements for 6 weeks 
and repeated the LIST protocol (LIST 2) by the end of the 
intervention period. The muscle damage and performance 
indices were again monitored for 72 h.
A week before LIST 1 subjects visit the laboratory for 
the preliminary screening, cardiopulmonary assessment 
and familiarization of all experimental procedures and 
LIST protocol. On the day of LIST 1, players arrived at the 
laboratory between 07:00 and 08:00 am after an overnight 
fast. A resting blood sample was taken and muscle strength, 
jumping performance, perceived muscle soreness and body 
composition were assessed. Afterwards, subjects consumed 
a standard meal consisting of two whole grain bread slices, 
a slice of smoked turkey fillet, 30 g of yellow Swiss cheese 
and a 240 ml of fresh orange juice (giving approximately 
397 kcal; 59 g carbohydrates, 11 g fat, 15 g protein). EIMD 
biochemical markers, through venous blood samples, mus-
cle performance and perceived muscle pain were evaluated 
2, 24, 48 and 72 h post-LIST. Participants who successfully 
completed LIST 1 were randomly allocated to WP or BC 
group and received 3.2  g/day of WP or BC, respectively, 
for 6 weeks. By the end of the supplementation period all 
volunteers repeated the experimental protocol (LIST 2) and 
evaluations with the same order and time intervals.
The experimental protocol took place during the com-
petitive period of the soccer season. During the whole pro-
tocol period, subjects were instructed to keep their usual 
eating habits and to restrain from any additional vitamin, 
antioxidant and performance-enhancing dietary supple-
mentation or recovery treatment. Compliance to the pro-
tocol was checked with 24-h recalls. Subjects were also 
instructed to abstain from exhaustive exercise for 72-h pre- 
and post-LISTs and followed a standardized training regi-
men. During the whole supplementation period, with the 
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exception of the 72-h pre- and post-LIST periods, the play-
ers were engaged in their habitual soccer training routine 
that included 4–5 training sessions and one official match 
per week. A detailed depiction of the experimental design 
is shown in Fig. 1.
Ethics
The protocol was approved by the Ethical Committee of 
Harokopio University. All procedures performed in stud-
ies involving human participants were in accordance with 
the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki declaration 
and its later amendments or comparable ethical standards. 
Informed consent was obtained from all individual partici-
pants included in the study.
Subjects
For the purposes of the study 25 soccer players from the 
third and fourth division of the Greek National league were 
initially recruited (Fig. 2). Exclusion criteria were medical 
treatment, history of cardiovascular or any other inflamma-
tory disease, cold or flu, acute respiratory infection, dental 
problems, renal/hepatic abnormalities, lactose intolerance 
and recent history of muscle injuries. Three of them were 
excluded from the study either because they did not meet 
the inclusion criteria or they declined participation. The 
rest of them (N = 22) completed the pre-supplementation 
LIST (LIST 1) and allocated to either the placebo group 
(WP, N = 11) or the bovine colostrum group (BC, N = 11). 
Three volunteers from the WP group and one volunteer 
from the BC group could not complete the intervention 
protocol due to upper respiratory tract infection and muscle 
strain. At the end, eight volunteers of the WP group and 
ten volunteers of the BC group completed the post-supple-
mentation LIST (LIST 2) (Fig. 2). The WP group consisted 
of one defender, five midfielders, one full back/winger 
and one central attacker while BC group consisted of four 
defenders, four midfielders, one full back/winger and one 
central attacker.
Sample size determination
To evaluate standardized differences in CK levels equal to 
20%, a sample size of 10 participants per each group was 
considered adequate to achieve statistical power >0.90 at 
significance level of p < 0.05 of two-sided hypotheses. 
Fig. 1  Schematic representation of the experimental protocol
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Despite the fact that we finished with less subjects in the 
WP group (n = 8), the working sample was also adequate to 
achieve statistical power equal to 90% having the aforemen-
tioned conditions.
Randomization
A random sequence of numbers (i.e., 01001…) was created 
by an algorithm in MS Excel. Participants were allocated to 
BC (if 0) or WP (if 1).
Supplementation
Participants of the BC group received 3.2  g/day (8 cap-
sules  ×  400  mg of BC per capsule) of a commercially 
available bovine colostrum containing 378 kcal, 67 g pro-
tein, 17 g carbohydrates and 4.7 g fat per 100 g (Colostrum 
Compact, LR Health and Beauty Systems, Germany) while 
the WP group received 3.2  g/day of commercially avail-
able whey protein (8 capsules  ×  400  mg of WP per cap-
sule) without flavoring and sweeteners (Ener Zona Proteine 
Whey 90%, Italy) containing 369 kcal, 90  g protein, 1  g 
carbohydrates and 0.5  g fat per 100  g. The whey protein 
was encapsulated in capsules, provided by LR, which were 
identical with the ones containing BC. The participants 
were advised to consume 4 capsules twice per day, half an 
hour before breakfast and dinner and were given 3 identi-
cal 56-capsule boxes containing either BC or WP, enough 
for a specific supplementation period of 3 weeks. By the 
end of the third week subjects were given the last four cap-
sule boxes containing enough capsules for the remaining 
3 weeks plus the 4 days of LIST 2. Then they were asked to 
record their daily supplementation consumption and bring 
back the boxes with the remaining capsules inside them. A 
85 and 82% adherence was recorded for the WP and BC 
group, respectively.
Loughborough Intermittent Shuttle Test
The 90-min shuttle run test was conducted according to 
Thompson et  al. in an artificial surface soccer pitch [20]. 
Volunteers were required to run between two lines, 20  m 
apart, at various speeds dictated by an audio signal based 
on the velocities corresponding to their individual 55 and 
95% of VO2max. The protocol consisted of 5 blocks of con-
tinuous running separated by 3  min of passive recovery 
for a total duration of 90 min. Heart rate was recorded via 
telemetry at 5-s intervals (Polar Team2 Pro, Polar, Finland) 
and averaged for each set (Fig. 1).
Anthropometric and body composition measurements
Body weight and standing height were measured in light 
clothing, without shoes using a digital scale (Seca 861; 
Hamburg, Germany) with an accuracy of 0.1  kg and a 
stadiometer (Seca Leicester Height Measure; Seca, Vogel 
& Halke) to the nearest 0.1  cm. Body composition was 
assessed by DXA (Lunar, Corporation, Brussels, Belgium) 
set at medium speed and according to the manufacturer’s 
instructions [21].
Nutritional assessment
Dietary intake before supplementation was assessed by 
three 24-h recalls which were collected the week before 
LIST 1 (two weekdays and one weekend). Similarly, dietary 
Fig. 2  Flowchart of volunteers’ 
recruitment
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intake after supplementation was assessed by three more 
24-h recalls, collected the week before LIST 2. The type of 
foods consumed (e.g., in terms of fat-content, brand name, 
constituents of mixed dishes, etc.), and the quantities or 
volumes were recorded in detail, using common household 
or other measures. Data from recalls were analyzed for their 
energy, macro- and micronutrient content by the Nutrition-
ist Pro, version 2.2 software (Axxya Systems-Nutritionist 
Pro, Stafford, TX, USA), using a hand-coding procedure. 
The Nutritionist Pro food database was expanded by adding 
analyses of traditional Greek food and recipes.
Cardiopulmonary assessment
The players performed an incremental (0.5  km/h increase 
each 1  min step) treadmill (Technogym Runrace, Gam-
bettola, Italy) test until voluntary exhaustion to determine 
maximal oxygen uptake (VO2max), maximal heart rate 
(Polar Electro, Finland) and running speeds corresponding 
to 55 and 95% of VO2max. Expired respiratory gas fractions 
were measured using an open circuit breath-by-breath auto-
mated gas-analysis system (Vmax 229D, Sensormedics, 
Yorba Linda, CA).
Maximum isometric voluntary contraction (MIVC)
During their first visit at the laboratory all subjects per-
formed a specific submaximal protocol on the isokinetic 
dynamometer (BIODEX System 3 Pro, NY, USA) to famil-
iarize with the isokinetic device and test procedure. Before 
muscle function measurements, subjects perform a stand-
ardized warm-up consisting of 5-min period on a cycle 
ergometer (Monark E-824) with a fixed load correspond-
ing to 2% of body weight. MIVC of the knee extensors was 
measured at a knee joint angle of 90° (0° = full knee exten-
sion). The subjects were instructed to kick as hard and fast 
as they could for five maximal repetitions lasting 5 s sepa-
rated by 60 s of rest. The three MIVC trials were averaged 
together to give the score for that particular measurement 
period.
Jump performance
Squat jump (SQJ) and countermovemt jump (CMJ) tests 
were conducted using a photocell device (Optojump, 
Microgate, Italy) according to Bosco et  al. [22]. Subjects 
warmed up for 5  min of on a stationary bicycle and per-
formed 2 sets of 6 reps of submaximal SQJ and CMJ jumps 
by bending the knees to a preferred starting push-off posi-
tion for CMJ and from a fixed knee bent at 90° for SQJ. 
For both jumping techniques hands were placed on hips. 
Then 3 maximal jumps were executed for each technique. 
A minimum of 2-min rest was allowed between jump trials. 
The highest vertical jump (cm) and the longest flying time 
(s) were registered and used for data analyses.
Perceived muscle soreness (PMS)
Subjects self-reported muscle soreness by performing 3 full 
squat movements and passive stretching of specific mus-
cles (quadriceps, hamstrings, abductors, adductors and gas-
trocnemius). We used a visual analog scale (VAS) from 0 
(absence of soreness) to 10 (extremely sore) and a visual 
hologram of human muscles [20] where subjects pointed at 
the specific muscle area and rated the soreness.
Blood sampling and biochemical assays
Venous blood samples were obtained from each subject. 
Complete blood count was determined in EDTA anticoag-
ulated whole blood with a Mindray BC-3000 hematology 
analyzer (Mindray, Shenzhen, P.R. China). The activity of 
creatine kinase (CK) was determined spectrophotometri-
cally by a commercially available kit (Biosis, Athens, 
Greece) modified for 96-well plates according to manufac-
turer’s instructions. High-sensitivity CRP and IL-6 were 
determined in serum by commercially available ELISA kits 
(Quantikine, R&D Systems, Abingdon, UK).
Statistical analysis
Quantitative variables are reported as median with inter-
quartile range (25th percentile–75th percentile) and quali-
tative, as frequencies. In order to estimate the response of 
each variable across the whole recovery period incremen-
tal, areas under the characteristic curve (iAUCs) were cal-
culated for each variable by the trapezoid rule. Due to the 
small sample size and the skewed distribution we used the 
non-parametric Mann–Whitney test to compare: (a) the 
pre-LIST (baseline) values of WP and BC pre-supplemen-
tation and post-supplementation and (b) the iAUCs of WP 
and BC groups’ pre-supplementation and post-supplemen-
tation. A non-parametric analysis for repeated measures 
(Friedman test) was also applied to identify significant 
changes of VAS indices over time. Post hoc analysis with 
Wilcoxon signed-rank tests was conducted with a Bonfer-
roni correction applied due to multiple comparisons, result-
ing in a significance level set at p < 0.01. Comparison of the 
response curves (WP LIST 1 vs WP LIST 2, BC LIST 1 vs 
BC LIST 2, WP LIST 1 vs BC LIST 1 and WP LIST 2 vs 
BC LIST 2) were performed using a two-way (trial × time) 
repeated-measures ANOVA, using log-transformed vari-
ables to reduce non-uniformity of error. ANOVA models 
incorporated a Greenhouse–Geisser correction for multi-
sample asphericity. Any significant main effects identified 
in the ANOVA were further analyzed for post hoc paired 
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t tests with Holm–Bonferroni correction. All statistical 
calculations were made with SPSS version 21.0 (Statisti-
cal Package for Social Sciences, SPSS, Chicago, Illinois, 
USA).
Results
The WP and BC groups shared similar anthropometric, 
training, performance, hematological and biochemical pre-
exercise characteristics that did not change after the 6-week 
supplementation period (Table 1). Dietary analysis did not 
reveal any significant differences in macronutrient intake 
between LIST 1 and LIST 2, neither for the WP group, nor 
for the BC group. In detail, energy intake for WP group 
was 2633 ± 472 vs 2711 ± 728 kcal (protein: 17.8 ± 3.7 vs 
18.3 ± 3.6%, carbohydrates: 44 ± 8.4 vs 38.9 ± 7.8%, fat: 
38.9 ± 8.9 vs 38.1 ± 5.6%) and for BC group 2676 ± 562 
vs 2582 ± 372 kcal (protein: 19.3 ± 3.4 vs 18.2 ± 5.1%, 
carbohydrates: 43 ± 7.4 vs 43.9 ± 71.6%, fat: 36.4 ± 5.4 
vs 38.6 ± 56.6%) for LIST 1 vs LIST 2, respectively. No 
differences between the dietary intake of WP and BC were 
also observed before LIST 1 or LIST 2.
The pre-supplementation kinetics of the measured vari-
ables (LIST 1) demonstrated either transient or sustained 
changes from baseline values in both groups indicating 
the ability of LIST to induce post-exercise hematological, 
biochemical and performance alterations (Tables  2, 3; 
Figs.  3, 4, 5, 6). Specifically, an acute but transient, two-
fold increase, of WBC is observed 2h post-LIST 1. The 
rapid elevation of circulating WBC is attributed to a ~2.5-
fold increase of granulocytes although a significant 30% 
decline of lymphocytes was also observed at the same time 
point. The leukocyte levels returned to baseline values 
at 24 h and remained there up to 72 h post-LIST 1. Con-
cerning the exercise performance indices, a sustained sig-
nificant decline of all markers (MIVC, SQJ and CMJ) was 
observed from 2 to 48 h post-LIST 1. MIVC declined ~8 
to 10% from 2 to 48 h, CMJ declined ~8 to 10% from 24 to 
48 h while a 7–9% decline of SQJ was observed at 24–48 h. 
Moreover, a significant increase of perceived muscle pain 
in all muscle groups was evident, mainly at 24–48 h. The 
greater increase was found in knee extension and flexion 
muscles. Finally, CK values started to elevate 2-h post-
LIST 1 but peaked at 24 or 48 h depending on the volun-
teer (3- to 4-fold increase). A delayed increase, at 24–48 h 
(fivefold), was demonstrated for CRP while the increase of 
IL-6 was acute showing a fourfold peak at 2h post-exercise 
and a return to basal levels at 24 h. The comparison of the 
iAUCs of all measured variables after LIST 1 demonstrated 
no significant differences between WP and BC groups indi-
cating that the response to the LIST protocol, for all meas-
ured EIMD variables, was similar between the two groups 
(data not shown).
Table 1  Baseline, pre-LIST, 
characteristics of volunteers in 
the WP and BC groups
Results are given as median (interquartile range). No significant differences were observed between the 
pre-LIST 1 values of WP and BC or between the pre-LIST 2 values of WP and BC (Mann–Whitney U 
test). No significant differences were observed between the pre-LIST 1 and pre-LIST 2 values of WP group 
and between the pre-LIST 1 and pre-LIST 2 values of BC group (Wilcoxon signed-rank test)
LIST 1 LIST 2
WP BC WP BC
Age (years) 21.5 (19.5–22.2) 22.0 (19.5–23.2) 21.5 (19.5–22.2) 22.0 (19.5–23.2)
BMI (kg/m2) 22.9 (22.2–23.4) 23.6 (22.8–24.1) 23.0 (22.3–23.6) 23.3 (22.8–23.9)
Training (min/week) 505 (397–637) 570 (417–600) 520 (367–621) 552 (400–588)
Total fat (% of BW) 13.4 (10.8–15.2) 14.1 (10.5–14.4) 13.4 (11.0–14.7) 14.7 (11.4–15.9)
VO2max (mL/kg/min) 51.4 (49.5–54.3) 53.7 (51.8–54.3) 51.0 (49.2–54.0) 52.3 (50.4–54.1)
MI VC (Nm) 321 (269–337) 349 (274–375) 315 (242–374) 299 (260–365)
CMJ (cm) 34.1 (31.3–37.8) 36.5 (32.3–38.6) 33.6 (32.8–38.0) 34.8 (32.7–37.5)
SQJ (cm) 30.8 (29.4–35.4) 34.3 (30.4–36.6) 32.0 (30.1–36.4) 33.1 (29.5–34.6)
White blood cells  (103/μL) 6.2 (5.0–6.9) 5.5 (4.9–5.9) 6.2 (5.7–6.8) 5.3 (4.8–6.3)
Lymphocytes  (103/μL) 2.2 (2.0–2.6) 2.2 (1.9–2.4) 2.5 (2.0–2.8) 2.4 (1.8–2.6)
Neutrophils  (103/μL) 3.5 (2.3–4.2) 2.6 (2.4–3.5) 3.6 (3.1–6.1) 2.9 (2.2–4.2)
Erythrocytes  (106/μL) 5.19 (4.92–5.44) 5.06 (4.65–5.77) 5.02 (4.87–5.39) 5.13 (4.71–5.47)
Hemoglobin (g/dL) 15.3 (14.4–16.6) 15.5 (14.3–15.9) 15 (14.1–15.6) 14.7 (13.9-15.05)
Platelets  (103/μL) 222 (199–249) 226 (192–238) 210 (166–286) 199 (180–249)
Creatine kinase (U/L) 168 (102–396) 152 (100–249) 143 (79–358) 174 (108–249)
C-reactive protein (mg/dL) 0.27 (0.18–0.41) 0.40 (0.21–0.57) 0.29 (0.18–0.90) 0.46 (0.33–0.65)
IL-6 (pg/mL) 0.61 (0.40–0.86) 0.62 (0.42–1.0) 0.65 (0.42–1.11) 0.78 (0.55–0.96)
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In order to assess whether the 6-week supplementation 
with either WP or BC was able to change the volunteers’ 
response to the LIST protocol, we compared the kinetics 
of the measured variables pre- and post-supplementation 
(WP LIST 1 vs WP LIST 2 and BC LIST 1 vs BC LIST 2 
and) for each group, separately. Specifically, we compared 
the absolute values and percent changes at each time point 
along with the iAUC of LIST 1 and LIST 2 for every volun-
teer in a pair-wise fashion. In addition, a direct comparison 
between groups was made before (WP LIST 1 vs BC LIST 
1) and after supplementation (WP LIST 2 vs BC LIST 2).
Concerning the leukocyte counts no significant differ-
ences of WBC, granulocytes and lymphocyte kinetics were 
observed after LIST 2 compared to LIST 1, either in the 
WP or the BC group, indicating that neither WP nor BC 
supplementation were able to alter the leukocytes response 
to LIST (Table 2). Direct comparisons of WP vs BC before 
and after supplementation also showed no differences 
between groups in the exercise-induced changes of the 
hematological markers although a higher iAUC for lym-
phocytes (p = 0.017) was observed in the BC group com-
pared to WP group after LIST 2 (Table 2).
Comparison of the VAS recordings at individual time 
points or as iAUC demonstrated no significant differences 
of delayed-onset muscle soreness in none of the five mus-
cle groups between LIST 1 and LIST 2 in both groups 
with the exception of lower VAS recordings of the knee 
flexors after post-supplementation LIST 2 in the WP 
group (Table 4, Supplemental material).
When the performance responses were compared, 
similar declines for MIVC and CMJ were observed for 
LIST 1 and LIST 2 in both groups (Table  3). However, 
a faster recovery of the SQJ performance was observed 
only in the BC group which was reflected in a significant 
trial  ×  time interaction (p = 0.001) between BC LIST 1 
and BC LIST 2, a significant intervention  ×  time inter-
action between WP LIST 2 and BC LIST 2 and a bet-
ter SQJ performance 48h post-LIST 2 compared to 
post-LIST 1 in the BC group. Although absolute values 
could not show a significant trial effect and intervention 
effect, when ANOVA analysis was conducted with the % 
changes of SQJ values (data not shown) significant differ-
ences were observed between BC LIST 1 and BC LIST 2 
(ptrial = 0.048) and between WP LIST 2 and BC LIST 2 
(pintervention = 0.010). In addition, less negative iAUCs 
were recorded for the nine out of ten volunteers in the 
BC group. This trend was not observed for the WP group 
(Fig. 3).
Fig. 3  Changes of SQJ and comparison of iAUCs in response to 
LIST pre- and post-supplementation. ap  <  0.05 vs pre-LIST 1 val-
ues, bp  <  0.05 vs pre-LIST 2 values. SQJ values were log trans-
formed prior to ANOVA analysis. WP LIST 1 vs WP LIST 2 (two-
way ANOVA main effects): p(trial)  =  0.751; p(time)  ≤  0.001; 
p(trial  ×  time)  = 0.190. BC LIST 1 vs BC LIST 2 (two-way 
ANOVA main effects): p(trial)  =  0.893; p(time) <0.001; 
p(trial  ×  time)  =  0.001. WP LIST 1 vs BC LIST 1 (two-way 
ANOVA main effects): p(intervention)  =  0.680; p(time)  ≤  0.001; 
p(intervention  ×  time)  =  0.207. WP LIST 2 vs BC LIST 2 (two-
way ANOVA main effects): p(trial)  =  0.819; p(time)  ≤  0.001; 
p(trial × time) = 0.065
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Fig. 4  Changes of CK and comparison of iAUCs in response 
to LIST pre- and post-supplementation. ap  <  0.05 vs pre-LIST 
1 values, bp  <  0.05 vs pre-LIST 2 values. CK and iAUC val-
ues were log transformed prior to ANOVA analysis. WP LIST 1 
vs WP LIST 2 (two-way ANOVA main effects): p(trial) = 0.833; 
p(time)  ≤ 0.001; p(trial ×  time) = 0.743. BC LIST 1 vs BC LIST 2 
(two-way ANOVA main effects): p(trial) = 0.799; p(time)  ≤  0.001; 
p(trial  ×  time) = 0.056. WP LIST 1 vs BC LIST 1 (two-way 
ANOVA main effects): p(intervention) = 0.492; p(time)  ≤  0.001; 
p(intervention  ×  time) = 0.527. WP LIST 2 vs BC LIST 2 (two-
way ANOVA main effects): p(trial) = 0.671; p(time)  ≤  0.001; 
p(trial × time) = 0.246
Fig. 5  Changes of CRP 
and comparison of iAUCs 
in response to LIST pre- 
and post-supplementation. 
ap < 0.05 vs pre-LIST 1 
values, bp < 0.05 vs pre-LIST 
2 values. CRP and iAUC 
values were log transformed 
prior to ANOVA analysis. WP 
LIST 1 vs WP LIST 2 (two-
way ANOVA main effects): 
p(trial) = 0.632; p(time)  ≤ 
0.001; p(trial × time) = 0.663. 
BC LIST 1 vs BC LIST 2 
(two-way ANOVA main 
effects): p(trial) = 0.544; p(time) 
≤ 0.001; p(trial × time) = 0.014. 
WP LIST 1 vs BC LIST 1 
(two-way ANOVA main 
effects): p(intervention) = 0.417; 
p(time) ≤ 0.001; 
p(intervention × time) = 0.615. 
WP LIST 2 vs BC LIST 2 
(two-way ANOVA main 
effects): p(trial) = 0.717; 
p(time) ≤ 0.001; 
p(trial × time) = 0.038
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When the responses of the biochemical markers were 
compared between pre- vs post-supplementation LISTs, we 
observed a non-significant trend for lower elevations of CK 
activity post-LIST 2 compared to post-LIST 1 only in the 
BC group. This trend reached statistical significance 24 h 
after LIST (Fig. 4). A direct comparison between WP and 
BC after the supplementation demonstrated a trend for a 
lower iAUCs in the BC group compared to the WP group 
after LIST 2 (p = 0.081) (Fig. 4).
A significant time  ×  trial interaction for CRP kinetics 
was observed only in the BC group without any significant 
trial effect (Fig.  5). Lower CRP values were observed at 
72h after LIST 2 compared to LIST 1 only in the BC group. 
No significant difference between the iAUCs of the trials 
was found (Fig. 5). When ANOVA analysis was conducted 
with the % changes of CRP values (data not shown) signifi-
cant differences were observed between BC LIST 1 and BC 
LIST 2 (p for trial = 0.038) and between WP LIST 2 and 
BC LIST 2 (p for intervention = 0.031).
Finally, significantly lower increments of IL-6 were 
observed in LIST 2 compared to LIST 1 only in the BC 
group when we compared the iAUCs (Fig. 6) and the per-
cent changes from baseline 2h after LIST [LIST 1: 351% 
(243–601%); LIST 2: 254% (178–339%), p = 0.028].
Discussion
The present study aimed to investigate the ability of a long-
term, low-dose BC supplementation to enhance the recov-
ery process of soccer players after a simulated soccer match 
(LIST) by alleviating EIMD symptoms. The outcomes of 
the study demonstrate a trend for BC supplementation to 
maintain performance (SQJ decline) and attenuate post-
exercise increments of CRP, CK and IL-6 in contrast to WP 
supplementation.
LIST protocol is a well-established, soccer simulation 
protocol able to induce similar responses to a typical soc-
cer match but in a more controlled fashion [19, 20]. For 
this reason, LIST has been widely used in supplementation 
studies which were mainly focused on the potential ergo-
genic effect in exercise performance [10, 23] fuel replen-
ishment [24] and fluid balance [25]. On the other hand, 
only few supplementation studies have implemented LIST 
or other simulated soccer pattern activities [6, 26] and real 
soccer matches [8] to examine the alleviation of EIMD on 
clinical and biochemical features. Compared to other stud-
ies we adopted a relatively long-term (>4 weeks) and low-
dose (3.2 g/day vs 20–60g/day in other studies) supplemen-
tation protocol where the efficacy of the supplementation 
Fig. 6  Changes of IL-6 and comparison of iAUCs in response 
to LIST pre- and post-supplementation. ap  <  0.05 vs pre-LIST 
1 values, bp  <  0.05 vs pre-LIST 2 values. IL-6 and iAUC val-
ues were log transformed prior to ANOVA analysis. WP LIST 1 
vs WP LIST 2 (two-way ANOVA main effects): p(trial) = 0.853; 
p(time)   ≤ 0.001; p(trial ×  time) = 0.529. BC LIST 1 vs BC LIST 2 
(two-way ANOVA main effects): p(trial) = 0.445; p(time)   ≤  0.001; 
p(trial  ×  time) = 0.218. WP LIST 1 vs BC LIST 1 (two-way 
ANOVA main effects): p(intervention) = 0.302; p(time)  ≤  0.001; 
p(intervention  ×  time) = 0.392. WP LIST 2 vs BC LIST 2 (two-
way ANOVA main effects): p(trial) = 0.757; p(time)   ≤ 0.001; 
p(trial × time) = 0.447
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was assessed in a repeated measures design. For the dosage 
quantity we decided that it should be close enough to the 
recommendations of the company (800 mg/day). We specu-
late that the high bioavailability of BC in combination with 
the high quality would be enough to modulate post-exercise 
kinetics. Despite WADA’s statement that “Colostrum is not 
prohibited per se, however it contains certain quantities of 
IGF-1 and other growth factors which are prohibited and 
can influence the outcome of anti-doping tests” (https://
www.wada-ama.org/en/questions-answers/prohibited-
list#item-388) it is unlikely that our dose scheme could 
elicit a positive doping test result. The study of Kuipers 
et al. clearly showed that a 20-fold higher supplementation 
dose than ours (60 g/day of BC powder), could not change 
blood IGF-I or IGF binding protein-3 levels and does not 
elicit positive results on drug tests [27].
In order to attenuate the high inter-individual variabil-
ity of such protocols, we compare the response of the same 
volunteer to LIST pre- and post-supplementation. Moreo-
ver, for the simulation of real field settings we incorporated 
the experimental period during the in-season soccer period. 
Subjects were committed to a typical soccer training micro-
cycle where a team trains on average >6 times and plays 
one official game per week. During the period of 3 days 
preceding and 4 days following the LIST, the training load 
was fixed and controlled by specific training instructions 
made by our team (Fig. 2). Considering the training back-
ground and the engagement in daily training and weekly 
soccer team routine, we assumed that the repeated bout 
effect would not be an issue in our experimental conditions.
Our LIST protocol induced similar changes to perfor-
mance, biochemical and hematological markers of EIMD 
compared to other studies [1, 28, 29]. In contrast to other 
similar studies we estimated PMS separately in five leg 
muscle groups. Due to the eccentric nature of the LIST pro-
tocol, a significant increase of perceived muscle pain was 
observed in all muscle groups but was more pronounced in 
knee extensors and flexors since they receive the majority 
of the work load during the acceleration and decelerations 
phase. Especially the knee flexors contract eccentrically 
during soccer actions such as kicking, sprinting or chang-
ing of directions in order to decelerate thigh and leg move-
ments prior to foot landing [30].
In agreement to our study, the presence of leukocytosis, 
immediately post-exercise, has also been observed after 
both LIST and soccer matches although our study showed 
in a more emphatic way that this leukocytosis is attributed 
to a dramatic increase of granulocytes, despite a concomi-
tant decrease of lymphocytes 2h post-LIST. Similar acute 
neutrophilia and lymphopenia was observed after a soc-
cer match in both male [31] and female players [32] while 
other studies were unable to observe this pattern [26, 33]. 
The main mechanism underlying the exercise-induced 
lymphopenia is the egress of certain lymphocyte sub-
types (NK cells, γδ Tcells,  CD8+ T cells) from the blood 
to peripheral tissues under the influence of glucocorticoids 
while lymphocyte apoptosis seems to be of minor impor-
tance for the observed lymphopenia [34].
Finally, post-exercise elevations of EIMD biochemical 
marker were in accordance with similar studies after both 
LIST [7, 28] and soccer protocols [1, 35, 36]. However, 
the magnitude of the CK increase was lower in our study 
compared to others [7, 28] probably because our volunteers 
were soccer players, therefore accustomed to the eccentric 
loads of LIST, especially since the experimental phase took 
place during the competitive period of the year. Similar CK 
increments were observed in the work of [3] where volun-
teers were also competitive soccer players in full training 
and match schedule.
Both LIST and real soccer matches have been previously 
used by research to assess the potential beneficial effect 
of dietary supplements on exercise performance of soccer 
players. However, studies investigating the ability of sup-
plements to alleviate symptoms of EIMD are scarce and 
give contradictory results due to different methodological 
procedures, dose schemes and biochemical measurements. 
Supplementation with vitamin C [37], a mixture of anti-
oxidant vitamins [7], beta-alanine [10] and green tea poly-
phenols [38] could not attenuate clinical and biochemical 
symptoms of EIMD after LIST or similar intermittent tests. 
On the other hand, DHA supplementation showed a ben-
eficial effect on oxidative stress and inflammatory response 
after an acute exercise session in soccer players [11]. It is 
therefore obvious that dietary supplementation in soccer 
players has not been studied thoroughly and the supple-
ments used until now are incapable of exerting protection 
against EIMD. This is probably because most of them con-
tain one or few active ingredients with a specific action 
(e.g., radical scavenging activity), while EIMD is a multi-
factorial process.
On the other hand, BC is the only naturally produced 
multi-ingredient supplement. It contains a milieu of bio-
active nutrients and microconstituents with antimicrobial 
and immunomodulatory properties mainly in the alimen-
tary tract, such as lactoferrin, lactoperoxidases, lysozyme, 
IGF-1/2, peptides and oligosaccharides [14, 39]. The effect 
of BC supplementation on several aspects of exercise per-
formance and body composition has been extensively stud-
ied before; however, the results are contradictory [13]. 
This can be mainly due to differences in the experimental 
design, source and composition of BC, dosage schemes 
and subject’s fitness level and training background. How-
ever, promising results were obtained when BC was studied 
for its ability to attenuate post-exercise immune suppres-
sion which is achieved through several mechanisms that 
include restriction of post-exercise decrements of IgG2 and 
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salivary IgA and lysozyme [40, 41], neutrophils degranu-
lation [40] and protection against exercise-induced gut 
hyper-permeability [17]. However, the efficiency of BC 
to protect against EIMD symptoms in soccer players has 
not been studied before although indirect evidences imply 
that BC may act as a recovery enhancer. Brinkworth et al. 
have shown that BC supplementation to active males (60 g/
day, 8 weeks) is able to improve performance in an exer-
cise bout 20  min after an initial bout of incremental run-
ning exercise to exhaustion [16]. A lower dose of BC (10 g/
day, 5 weeks) was also able to reduce fatigue after a 5 day 
high intensity training period in highly trained cyclists [42]. 
The mechanisms underlying the ability of BC to affect the 
recovery process after one bout of exercise are still specu-
lative. BC supplementation can increase resting levels of 
essential and branched-chain amino acids [43] which pro-
mote skeletal muscle synthesis and attenuate muscle dam-
age [44]. Moreover, an animal model has shown that BC in 
the absence of exercise is able to lower lipid hydroperox-
ides, increase the specific activity of superoxide dismutase 
and increase total antioxidant capacity in muscle tissues of 
rats. When supplemented along with exercise it was able 
to attenuate exercise-induced increases of lipid hydroperox-
ides and xanthine oxidase and exercise-induced decreases 
of SOD and TAC [18]. Finally, BC is able to protect epi-
thelial integrity and attenuate gut permeability partly by 
reducing temperature-induced apoptosis of epithelial cells 
and induction of the cytoprotective heat-shock proteins 
[17]. If similar mechanism were able to function in mus-
cle tissues then they could favorably modulate EIMD. In 
contrast to other studies, we decided to proceed with a low-
dose and relatively long-term dosage scheme which can be 
applied in real field settings, i.e., during the in-season soc-
cer period.
The results of this study demonstrated the ability of 
BC supplementation, in contrast to WP supplementa-
tion, to attenuate post-LIST increments of CK, CRP and 
IL-6 accompanied by an improvement of SQJ decre-
ments. BC could not significantly affect PMS, leukocyte 
counts, MICV, and CMJ kinetics, but instead it had a sig-
nificant beneficial effect in exercise performance taking 
into account the improvement in SQJ. It should be men-
tioned that post-supplementation pre-LIST indices were 
not affected by BC or WP indicating that BC effects could 
only be attributed to changes in the post-exercise plasticity 
of the subject’s muscle and inflammatory responses. The 
greater susceptibility of SQJ to BC supplementation is in 
accordance with the results of Byrne et al. who found that 
SQJ performance was affected to a greater extent after an 
eccentric protocol than the CMJ [45]. These results suggest 
that the stretch–shortening cycle used in the CMJ possibly 
masks the negative performance effects associated with the 
exercise-induced muscle damage. Perhaps the SQJ is more 
susceptible to the inflammatory response accompanying 
EIMD than CMJ, which is under the influence of a more 
complex control and governed by advanced neuromuscular 
and proprioceptive biofeedback mechanisms. Under this 
perspective, the mild anti-inflammatory properties of BC 
may more strongly affect SQJ than CMJ.
It is tempting to speculate that BC, by attenuating mus-
cle damage (CK and IL-6) can lead to a lower systemic 
inflammatory response. Whether this attenuation origi-
nates from a possible stabilization of muscle cells, which 
can induce a lower inflammatory response or the opposite, 
is not known. However, the anti-inflammatory properties 
of BC have been demonstrated both in cell and chronic 
inflammation models [14, 39], but these models do not nec-
essarily share similar pathophysiological features with the 
exercise-induced inflammation. Recently, Appukutty and 
co-workers [18] demonstrated the ability of BC supplemen-
tation to protect against exercise-induced oxidative stress 
in rat muscles in a dose (per kg of body weight) similar to 
ours. In addition, recent studies in athletes have shown the 
ability of BC to attenuate gut permeability after heavy exer-
cise in athletes [17]. It is therefore obvious that due to its 
multicomponent composition BC seems to exert pleiotropic 
beneficial action on post-exercise recovery. Whether these 
actions can be translated to long-term beneficial actions on 
recovery after intermittent exercise requires further mecha-
nistic and supplementation studies.
Our study is the first soccer-specific research that tracks 
EIMD kinetics and incorporates professional and semi-
professional soccer players accustomed to regular soccer 
eccentric training instead of amateurs and college students 
unaccustomed to eccentric exercise mode. In addition there 
was a high homogeneity between our subjects on their basic 
anthropometric, biochemical and exercise performance fea-
tures (i.e.,  VO2max, BMI, training background). Another 
advantage of the experimental design was the implemen-
tation of the supplementation phase during the in sea-
son period of the professional league. The soccer training 
micro-cycle per se can produce an additional load on mus-
culoskeletal system of the athlete and an added difficulty for 
the BC supplementation to overcome. We tried to simulate/
mimic the real soccer field settings even though we knew 
that regular high-intensity soccer practice, with the cyclic 
pattern of concentric and eccentric extension/flexion of the 
knee per se, might alter the athlete performance decline. 
To overcome the latter, we decide to incorporate a specific 
training program 3 days pre- and 4 days post-LIST without 
any additional eccentric load. In addition, we choose func-
tional testing like MICV, SQJ and CMJ that have minimum 
eccentric load and would not exaggerate or interfere with 
the EIMD symptoms caused by the LIST per se.
On the other hand, the low number of participants, 
the nature of the protocol which lacks soccer-specific 
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movements like tackling or shooting, the limited range of 
functional tests, the use of maximal isometric strength of 
the knee extensors instead of knee flexors which are more 
susceptible to soccer eccentric movement pattern and the 
use of just one dose of BC supplementation are among the 
limitations of the study.
In conclusion, the LIST protocol can induce EIMD 
and performance decrements in soccer players. EIMD and 
performance following LIST intervention may positively 
be affected by a low-dose administration of BC in soccer 
players. Larger studies are needed to confirm the ability of 
bovine colostrum to improve recovery after a soccer game.
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